Impressum Bookmark Kontakt Sitemap

Solide Tumoren - Verdauungstrakt - Ösophaguskarzinom -
Weiterführende Informationen

Ösophaguskarzinom

Leitlinien

 

Keine aktuellen Leitlinien der DKG, AIO oder DGVS publiziert.

 

NCCN Guidelines; Version 2.2011 (Registrierung erforderlich)

 

ESMO Clinical Practice guidelines: [3]

 

Studien

 

www.studien.de (DKG); www.eortc.be (EORTC); www.clinicaltrials.gov (NIH/USA); www.aio-portal.de

 

Literatur

 

  1. Kranzfelder M et al: Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Brit J Surg 2011; 98: 768-83
  2. Gaast AV et al: CROSS Study Group: Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study. J Clin Oncol 2010; 28:15s (suppl) abstr 4004
  3. Stahl M et al: Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (Suppl 5): v46–9
  4. Bedenne L et al: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160–8
  5. Grünberger B et al: Palliative chemotherapy for recurrent and metastatic esophageal cancer. Anticancer Res 2007; 27: 2705–14
  6. Kelsen D et al: Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 2007; 25: 3719–25
  7. Lorenzen S et al: Cetuximab plus cisplatin 5-fluorouracil versus cisplatin 5-fluorouracil alone in first-line metastastic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 2009; 20: 1667–73
  8. Malthaner et al: Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2006; 3: CD001556
  9. Martin MG et al: Second-line therapy for esophageal cancer. Expert Rev Anticancer Ther 2007; 7: 871–6
  10. Palmes D et al.: Diagnostic evaluation, surgical technique, and perioperative management after esophagectomy: consensus statement of the German Advanced Surgical Treatment Study Group. Langenbecks Arch Surg. 2011; 396: 857–66
  11. Stahl M: Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009; 27: 851–6
  12. Stein H et al: Early esophageal cancer: pro surgical resection. Chirurg 2011; 82: 495–9
  13. Vallböhmer D et al: Oesophageal cancer: current status of multimodality therapy.  Zentralbl Chir 2011; 136: 312–6
  14. Wijnhoven BPL et al: Neoadjuvant chemoradiotherapy for esophageal cancer: A review of meta-analyses. World J Surg 2009; 33: 2606–14